Clinical Trials on Viral Reactivation in Luxembourg
Total 15 results
-
Luxembourg Institute of HealthCentre Hospitalier du Luxembourg; University of Luxembourg; Laboratoire National... and other collaboratorsRecruiting
-
Luxembourg Institute of HealthCompletedCOVID-19 | Post-Acute COVID-19Luxembourg
-
Luxembourg Institute of HealthViewMindRecruiting
-
Luxembourg Institute of HealthCentre Hospitalier du Luxembourg; Laboratoires Réunis; Luxembourg National Research... and other collaboratorsCompleted
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
Janssen-Cilag International NVCompletedHepatitis C, ChronicUnited Kingdom, Belgium, Germany, Portugal, Russian Federation, Hungary, Ireland, Luxembourg
-
Institut National de la Santé Et de la Recherche...CompletedCorona Virus InfectionNorway, Austria, France, Greece, Portugal, Belgium, Luxembourg
-
Boehringer IngelheimCompletedHIV InfectionsArgentina, Austria, Belgium, Brazil, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
-
Janssen-Cilag International NVNo longer availableHepatitis CAustralia, Belgium, Germany, Spain, Switzerland, Romania, Serbia, Greece, New Zealand, Brazil, Russian Federation, Austria, Hungary, Czech Republic, Luxembourg
-
GlaxoSmithKlineCompletedHIV Infection | Infection, Human Immunodeficiency VirusUnited States, Belgium, France, Germany, Spain, Canada, Italy, Portugal, Romania, Austria, Switzerland, Poland, Latvia, Luxembourg
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited Kingdom, Argentina, Switzerland, France, Brazil, United States, Estonia, Spain, Australia, Peru, Austria, Belgium, Canada, Germany, Ireland, Israel, Italy, Japan, Lithuania, Luxembourg, Martinique, New Zealand, Norway, Poland, Puerto... and more
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Denmark, France, Germany, Greece, Italy, Mexico, Netherlands, Portugal, Spain, Switzerland, United Kingdom
-
Tibotec Pharmaceuticals, IrelandApproved for marketingHIV InfectionsUnited States, Belgium, Germany, Taiwan, Spain, Switzerland, Mexico, Slovenia, Malaysia, Turkey, Canada, Netherlands, Denmark, Greece, Sweden, Russian Federation, Czech Republic, Puerto Rico, Thailand, Hungary, Luxembourg, Venezuela
-
University of MinnesotaNational Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaboratorsCompletedHIV InfectionSpain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
-
Rigshospitalet, DenmarkUniversity College, LondonEnrolling by invitationEnd Stage Liver Disease | Cardiovascular Diseases | Fractures, Bone | Diabetes Mellitus | Renal Insufficiency | Hepatitis B | Hepatitis C | Kidney Failure, Chronic | Proteinuria | HIV | Coinfection | Acidosis, Lactic | AIDSSpain, Switzerland, Germany, United Kingdom, Austria, Sweden, Finland, Israel, Denmark, France, Italy, Iceland, Belgium, Slovakia, Norway, Lithuania, Portugal, Poland, Croatia, Czechia, Greece, Hungary, Luxembourg, Argentina, Belarus, Bosnia... and more